Dr. Qing Zeng
Dr. Zeng is an expert in rodent organ transplantation, including kidney, liver, heart, and islet transplants.
Search
Search results
632 results found
Alexander Klug
Zhen Zhang
I have been the lab manager since 2021. I earned my master’s degree in Law from Shanghai University in China. I have over 15 years of experience in customer service and education. My primary focus is laboratory management and logistics. Additionally, I culture and differentiate human iPSCs and...
Victoria Sanchez, Au.D., Ph.D., CCC-A
Dr. Vicky Sanchez is a clinician-scientist in the Department of Otolaryngology. She provides clinical services and leads research studies in the Auditory Rehabilitation & Clinical Trials Laboratory (ARCT Lab). The ARCT Lab is both federally and industry funded, and is a collaborative multi...
USF Neuroscience Institute Seminar Series
Dr. Gulick presented a new seminar on the multifactorial risk posed by the ALDH2*2 gene, which encodes an enzyme that breaks down acetaldehyde, and which is the causal factor in the Asian Glow effect of alcohol in many people, especially those of East Asian background.
New R44 Award from NIAAA
Dr. Gulick and her collaborators at Psilera, Inc. were just awarded a small business research grant from the National Institute on Alcohol Abuse and Alcoholism. This grant will enable them to study Psilera's novel compounds as potential treatments for alcohol addiction with fewer side effects than...
Appetitive motivational experience during adolescence results in enhanced alcohol consumption during adulthood.
Walker, Brendan M, and Cindy L Ehlers. 2009. “Appetitive Motivational Experience During Adolescence Results in Enhanced Alcohol Consumption During Adulthood.”. Behavioral Neuroscience 123 (4): 926-35.
alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol.
Walker, Brendan M, Dennis D Rasmussen, Murray A Raskind, and George F Koob. 2008. “Alpha1-Noradrenergic Receptor Antagonism Blocks Dependence-Induced Increases in Responding for Ethanol.”. Alcohol (Fayetteville, N.Y.) 42 (2): 91-7.
Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns.
Sharp, Thomas E, David J Lefer, and Steven R Houser. 2019. “Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns.”. JACC. Basic to Translational Science 4 (3): 422-24.
Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction.
Doiron, Jake E, Huijing Xia, Xiaoman Yu, Alexandra R Nevins, Kyle B LaPenna, Thomas E Sharp, Traci T Goodchild, et al. 2024. “Adjunctive Therapy With an Oral H2S Donor Provides Additional Therapeutic Benefit Beyond SGLT2 Inhibition in Cardiometabolic Heart Failure With Preserved Ejection Fraction.”. British Journal of Pharmacology 181 (21): 4294-4310.